PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-33.30%
Negative revenue growth while 6247.T stands at 9.09%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-39.40%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-3529.69%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1904.15%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-262.13%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-262.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-262.21%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.25%
Negative 10Y revenue/share CAGR while 6247.T stands at 65.46%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-28.34%
Negative 5Y CAGR while 6247.T stands at 20.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-14.36%
Negative 3Y CAGR while 6247.T stands at 4.48%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.57%
Negative 10Y net income/share CAGR while 6247.T is at 17.03%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-177.11%
Negative 5Y net income/share CAGR while 6247.T is 22.38%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-149.97%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
369.43%
10Y equity/share CAGR above 1.5x 6247.T's 50.92%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
47.76%
5Y equity/share CAGR above 1.5x 6247.T's 14.23%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
12.62%
3Y equity/share CAGR 1.25-1.5x 6247.T's 9.60%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.86%
Our AR growth while 6247.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.08%
We show growth while 6247.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.98%
Asset growth above 1.5x 6247.T's 1.67%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.56%
We have a declining book value while 6247.T shows 1.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
19.32%
We have some new debt while 6247.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-2.35%
We cut SG&A while 6247.T invests at 4.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.